SCUBA

CD274 — CD274 molecule

CD274 belongs to a gene co-expression module in 3 of 28 SCUBA cell types. Each module groups genes that rise and fall together in that cell type; the genes it shares a module with are its closest co-expression partners there.

CD274's module in each cell type

Cell typeModuleShares the module with
CD4⁺ T cellsPD-L1 checkpoint
Immune regulation
ADAM12, CASS4, CCDC88B, GALNT10, HUWE1, INPP5D, KIF3B, LASP1 +13 moreView in SCUBA
MacrophagesIFN-gamma Response
Inflammatory
ANKRD22, APOL2, ATF5, ATP13A1, CD300LF, CD40, CD48, CTSH +21 moreView in SCUBA
MonocytesNF-κB Counter-regulation
Inflammatory
ABL2, C15orf48, GPR84, IL1RN, RHOH, TNFAIP8, TNIP3View in SCUBA

About the gene

SynonymsB7-H, B7-H1, B7H1, PD-L1, PDCD1LG1, PDL1
Chromosome9: 5450503-5470566
Predicted locationMembrane, Secreted
Essential geneNo
Protein classCancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters
Molecular functionReceptor
Biological processAdaptive immunity, Immunity

Function

Plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/PD-1, modulates the activation threshold of T-cells and limits T-cell effector response. Through a yet unknown activating receptor, may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10). Can also act as a transcription coactivator: in response to hypoxia, translocates into the nucleus via its interaction with phosphorylated STAT3 and promotes transcription of GSDMC, leading to pyroptosis. The PDCD1-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and escape destruction by the immune system, thereby facilitating tumor survival. The interaction with PDCD1/PD-1 inhibits cytotoxic T lymphocytes (CTLs) effector function (By similarity). The blockage of the PDCD1-mediated pathway results in the reversal of the exhausted T- cell phenotype and the normalization of the anti-tumor response, providing a rationale for cancer immunotherapy (By similarity).

Human Protein Atlas · Open Targets · UniProt

Gene annotation from the Human Protein Atlas and UniProt; see sources & licences.